Mon compte

Résultats de recherche

Nombre de programmes trouvés : 7099

le (23m46s)

Randomised controlled trials, health agencies and consumer organisations

Randomised controlled trials, health agencies and consumer organisations: the case of Intrinsa and FlibanserinRandomized controlled trials (RCT) are now considered the ‘gold standard’ of clinical evidence (Timmermans, Berg, 2003), providing scientific and clinical proof, opening the door to the approval of new treatments by local health agencies, and legitimizing the use of a treatment. The studies of male circumcision for HIV prevention in several countries in Southern Africa constitute one of the clearest examples of such a use of RCTs by international public health agencies (WHO, UNAIDS), who here based the development of a public health recommendation on the publication ...
Voir la vidéo

le (24m41s)

Gouverner (par) les bactéries: la surveillance épidémiologique comme « dispositif-frontière »

Governing (through) bacteria: epidemiological surveillance as "boundary-device". The case of antimicrobial resistance in veterinary medicineThe problem of antimicrobial resistance emerged in the late 1990's. Most of bacteria being zoonotic, it concerns human medicine as well as veterinary medicine. In November 2011, the French ministry of Agriculture implemented a plan for the fight against antimicrobial resistance in veterinary medicine in order to better control the use of antibiotics in livestock production. One of the main measures of this policy is to reinforce the epidemiological surveillance system of bacteria of animal origin : the "Resapath". This presentation aims at studying how this epidemiological ...
Voir la vidéo

le (25m25s)

The rise of cost-effectiveness evidence in global health

The rise of cost-effectiveness evidence in global health: contingencies of ‘context’ and the politics of contingency The development and implementation of health policies in developing countries have become increasingly driven by the practices of research communities, inter- and non-governmental organisations, and donor agencies operating at the global level.  As part of this shifting landscape, commentators have noted the permeation of neo-liberal market-principles into global health with the rise of “philanthrocapitalism” and public-private partnerships, starting mostly in the 1990s. Thus, critics argue that the concurrent rise in demand for experimental evidence of cost-effectiveness reflects not simply the superior epistemic truth-value now attributed ...
Voir la vidéo

le (24m53s)

Flipping the Hierarchy of Evidence ?

Flipping the Hierarchy of Evidence ? : Rituals of Inversion and Subversion in the Inclusion of Qualitative Research in WHO GuidelinesEvidence-based medicine (EBM)—and its hallmark method, meta-analysis—have enjoyed rapidly increasing visibility and legitimacy since the early 1990s.  The many assumptions of EBM—that valid, universal knowledge can be produced, that knowledge synthesis can be rigorous and transparent, and that these syntheses will slot neatly into policy and practice—have come to appear self-evident.  The rhetoric of “evidence-based” practice frames evidence synthesis as both common sense, with respect to orthodox scientific method, and, paradoxically, a radical break with a past practice steeped in ...
Voir la vidéo

le (1h30m9s)

Usages politiques et sociaux du registre biomédical

Bauer SusanneModeling population health. Reflections on the performativity of epidemiological techniques in the age of genomics Like accounting in the world of business, practices of quantification at the population level are ubiquitous in the health sciences. Risk reasoning has become the common sense mode of knowledge production in the health sciences. Risk assessment techniques of modern epidemiology also co-shape the ways genomic data are translated into population health. The products of these computational practices – risk figures – fold into the very configurations of health matters, co-shaping the body politic in biomedical science, clinical practice and everyday life. In preventive medicine, ...
Voir la vidéo
Label UNT Conférences

le (33m17s)

Marqueurs tumoraux: nouvelles perspectives

Pour le cancérologue, il est essentiel de disposer d'indicateurs signalant de façon fiable la présence d'une tumeurs cancéreuses lorsqu'elle est encore de petite taille, non détectable à l'examen clinique. Il est aussi très important de posséder des marqueurs des états précancéreux. Les nouvelles technologies proposées par la biologie moléculaire vont permettre de proposer des tests de détection de plus en plus sensibles
Voir la vidéo

le (1h8m7s)

Espace public, Islam et modernité

Nilufer GÖLE est directrice d'études à l’EHESS après avoir longtemps été professeur de sociologie à l'université de Bogaziçi (Istanbul-Turquie). Elle est d’autre part chercheur au CADIS (Centre d’Analyse et d’intervention sociologiques) et membre du Conseil scientifique de l'Institut d’études de l’Islam et des sociétés du monde musulman (IISMM, EHESS) depuis 2000.Ses travaux sont consacrés à l'étude de nouvelles configurations entre la modernité et l'Islam, en particulier à l'émergence de nouvelles figures musulmanes dans l'espace public, dans une perspective comparative (Turquie, Iran, Europe, Etats-Unis). Elle est l'auteur, entre autres publications, de Musulmanes et modernes. Voile et civilisation en Turquie, paru en ...
Voir la vidéo

Facebook Twitter
Mon Compte